Gaps Between Guidelines and Clinical Practice Patterns in ASCVD

Experts on the management of ASCVD discuss clinical practice patterns of high-risk patients and the common reasons for clinicians not intensifying cholesterol treatment.

EP: 1.How Often Do Patients with ASCVD Achieve Target LDL-C?

Now Viewing

EP: 2.Gaps Between Guidelines and Clinical Practice Patterns in ASCVD

EP: 3.Comparing the ACC/AHA and ESC/EAS Cholesterol Management Guidelines

EP: 4.Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

EP: 5.Evaluating Non-Statin Lipid-Lowering Therapies in ASCVD

EP: 6.Clinical Efficacy of Non-Statin Treatment Options in ASCVD

EP: 7.Non-Statin Therapies: Cost Effectiveness and Clinical Evidence Gaps

EP: 8.Persistence and Discontinuation Rates for Non-Statin Therapies in ASCVD

EP: 9.The Role of Pharmacists in Treating Very High-Risk ASCVD

EP: 10.Valuable Metrics and Improving Adherence in Patients With ASCVD

EP: 11.Successful Collaborative Care Strategies for Pharmacists

Related Videos

Related Content

Advertisement

November 19th 2024

Abelacimab Reduces Bleeding in AF Patients on Antiplatelet Therapy

Alexandra Gerlach, Associate Editor

November 18th 2024

AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors

Aislinn Antrim, MA, Assistant Managing Editor

November 17th 2024

AHA 2024: Integrating Ambulatory Care Pharmacists in Value-Based Primary Care Improves Cardiometabolic Disease Management

Aislinn Antrim, MA, Assistant Managing Editor

November 16th 2024

AHA 2024: Providing Feedback for Pharmacists Improved Care for Veterans With Heart Failure

Aislinn Antrim, MA, Assistant Managing Editor

Published: November 16th 2024 | Updated: November 16th 2024

AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity

Aislinn Antrim, MA, Assistant Managing Editor

November 15th 2024

AHA 2024: AI Tool Could Provide Fast, No-Contact Blood Pressure and Diabetes Screenings

Aislinn Antrim, MA, Assistant Managing Editor

Related Content

Advertisement

November 19th 2024

Abelacimab Reduces Bleeding in AF Patients on Antiplatelet Therapy

Alexandra Gerlach, Associate Editor

November 18th 2024

AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors

Aislinn Antrim, MA, Assistant Managing Editor

November 17th 2024

AHA 2024: Integrating Ambulatory Care Pharmacists in Value-Based Primary Care Improves Cardiometabolic Disease Management

Aislinn Antrim, MA, Assistant Managing Editor

November 16th 2024

AHA 2024: Providing Feedback for Pharmacists Improved Care for Veterans With Heart Failure

Aislinn Antrim, MA, Assistant Managing Editor

Published: November 16th 2024 | Updated: November 16th 2024

AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity

Aislinn Antrim, MA, Assistant Managing Editor

November 15th 2024

AHA 2024: AI Tool Could Provide Fast, No-Contact Blood Pressure and Diabetes Screenings

Aislinn Antrim, MA, Assistant Managing Editor